Business Description
![Beam Therapeutics Inc Beam Therapeutics Inc logo](https://static.gurufocus.com/logos/0C0000BPMU.png?14)
Beam Therapeutics Inc
NAICS : 325411
SIC : 2833
ISIN : US07373V1052
Description
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.1 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -1.01 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.44 | |||||
Beneish M-Score | 0.46 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1598 | |||||
3-Year EBITDA Growth Rate | 9.5 | |||||
3-Year EPS without NRI Growth Rate | 15.7 | |||||
3-Year FCF Growth Rate | 0.4 | |||||
3-Year Book Growth Rate | 41 | |||||
Future 3-5Y EPS without NRI Growth Rate | -33.17 | |||||
Future 3-5Y Total Revenue Growth Rate | -43.58 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 67.16 | |||||
9-Day RSI | 57.38 | |||||
14-Day RSI | 53.77 | |||||
6-1 Month Momentum % | -10.8 | |||||
12-1 Month Momentum % | 29.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.81 | |||||
Quick Ratio | 5.81 | |||||
Cash Ratio | 5.69 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.6 | |||||
Shareholder Yield % | -2.79 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -52.31 | |||||
Net Margin % | -40.56 | |||||
FCF Margin % | -43.51 | |||||
ROE % | -16.48 | |||||
ROA % | -10.63 | |||||
ROIC % | -46.19 | |||||
ROC (Joel Greenblatt) % | -78.55 | |||||
ROCE % | -16.11 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.15 | |||||
PB Ratio | 2.59 | |||||
Price-to-Tangible-Book | 2.59 | |||||
EV-to-EBIT | -7.41 | |||||
EV-to-Forward-EBIT | -3.76 | |||||
EV-to-EBITDA | -8.39 | |||||
EV-to-Forward-EBITDA | -3.63 | |||||
EV-to-Revenue | 3.88 | |||||
EV-to-Forward-Revenue | 30.92 | |||||
EV-to-FCF | -8.91 | |||||
Price-to-Net-Current-Asset-Value | 3.55 | |||||
Price-to-Net-Cash | 3.68 | |||||
Earnings Yield (Greenblatt) % | -13.5 | |||||
FCF Yield % | -6.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BEAM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beam Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 352.567 | ||
EPS (TTM) ($) | -1.81 | ||
Beta | 2.08 | ||
Volatility % | 96.77 | ||
14-Day RSI | 53.77 | ||
14-Day ATR ($) | 1.607289 | ||
20-Day SMA ($) | 26.265 | ||
12-1 Month Momentum % | 29.02 | ||
52-Week Range ($) | 16.95 - 49.5 | ||
Shares Outstanding (Mil) | 82.42 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Beam Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Beam Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Beam Therapeutics Inc Frequently Asked Questions
What is Beam Therapeutics Inc(BEAM)'s stock price today?
The current price of BEAM is $26.81. The 52 week high of BEAM is $49.50 and 52 week low is $16.95.
When is next earnings date of Beam Therapeutics Inc(BEAM)?
The next earnings date of Beam Therapeutics Inc(BEAM) is 2024-11-08 Est..
Does Beam Therapeutics Inc(BEAM) pay dividends? If so, how much?
Beam Therapeutics Inc(BEAM) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |